- new product
Bridgewest Group launches NovaCina, new sterile injectable CDMO
MIAMI and PERTH, Australia, April 5, 2023 /PRNewswire/ -- Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, launches new Contract Development and Manufacturing Organization (CDMO) focused on sterile injectable drug products. This follows the recent announcement on the acquisition of the Perth sterile injectable manufacturing plant from Pfizer. The newly...
Read more